Objectives The oral microbiome plays a critical role in modulating systemic inflammation, partly through its interactions ...
Background Systemic lupus erythematosus (SLE) predominantly affects women of childbearing age and is often associated with ...
Objectives The intrauterine environment may influence childhood immune-mediated disease risk. We investigated whether ...
It is postulated that fibromyalgia reflects a neurobiologically rooted imbalance between overactivated threat systems and ...
Background Approximately 10%–20% of patients with Kawasaki disease (KD) are resistant to intravenous immunoglobulins (IVIG) ...
Objectives Eosinophilic granulomatosis with polyangiitis (EGPA) is classified as a subtype of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). A recent genome-wide association ...
DNA of gut microbiota can be found in synovium of osteoarthritis and rheumatoid arthritis. This finding could result from the translocation of still alive bacteria from gut to joints through blood, ...
The concept of spondyloarthritis (SpA) is clearly not new.1 Ever since 1974, axial inflammation and psoriasis (Pso) with psoriatic arthritis (PsA) have been part of the concept,2 3 except for the New ...
Objective To assess the effects of treatment with antitumour necrosis factor (TNF) agents, methotrexate, or other non-biological disease-modifying antirheumatic drugs (DMARDs) on cardiovascular event ...
Objectives To assess 52-week safety and efficacy of bimekizumab in patients with active psoriatic arthritis (PsA) and prior inadequate response/intolerance to tumour necrosis factor inhibitors.
Introduction The importance of patient-reported outcome measures (PROMs) for rheumatoid arthritis (RA) clinical studies has been recognised for many years. The current study aims to describe the RA ...